12-15 positions open for Research Assistants (Summer trainees) in TUT-BMT

The Faculty of Biomedical Sciences and Engineering (TUT-BMT) offers 12-15 research assistants (summer training) positions to work in Faculty’s research groups:

  • Personal Health Informatics
  • Laboratory of Biosystem Dynamics
  • Sensor Technology and Biomeasurements Group (STB)
  • Micro- and Nanosystems Research Group
  • Biomaterials and Tissue Engineering Group (BioTE)

Read more on Open positions at TUT webpage. Applications must be submitted by TUT online application formClosing date for applications is 26th March 2018.

2-4 positions open for University Lecturer / University Teacher (TUT-BMT)

The Faculty of Biomedical Sciences and Engineering (TUT-BMT) is a multidisciplinary unit of high-quality research and education in the fields of biomedical engineering and health technology. The faculty and its over 140 staff members are responsible for teaching and research in the fields of bioimaging, biomaterials, biomeasurement, biosensors and biorobotics, personal health technologies, experimental and computational biosciences, and cell and tissue technology.

The Faculty of Biomedical Sciences and Engineering works in close collaboration with the University of Tampere through the BioMediTech Institute, bringing together experts from many different disciplines of biosciences and biomedical engineering. At BioMediTech, the Faculty’s expertise in research is combined with expertise in medical science, biology, and behavioural sciences, creating new innovations and solutions in the fields of health and well-being.

We expect the candidate appointed as university teacher to hold an applicable higher university degree and possess good teaching skills. We especially appreciate broad expertise in the field of the research group, research experience, pedagogical merits, and the ability to produce teaching materials and use versatile teaching methods.

Read more on Open positions at TUT webpage. Applications must be submitted by TUT online application formClosing date for applications is 12th April 2018 (at 10.00 pm GMT).

Applications are now invited for three-year PhD positions in the FibreNet project

Fibres have a central role in determining the key characteristics of many everyday products. Tampere University of Technology (TUT) is coordinating the international FibreNet project that develops new tools and methods for controlling the properties of different products that contain bio-fibres.

The goal of the FibreNet project is to control the properties of fibre-based products throughout the production process from fibres to end products. The research activities are organized into PhD projects. The FibreNet consortium is made up of seven universities and eight companies from Europe.

According to FibreNet’s funding model, the researchers who will be working in Finland are hired from outside of Finland. The 11 positions available in the other European partner universities are open to MSc graduates who have completed their degree in Finland. Applications are now invited for three-year PhD positions in the FibreNet project. Four positions are open in Finland, three at TUT and one at Kemira. Positions are open at TUT in the Laboratory of Materials Science and the Micro and Nanosystems Research Group.

Read more from the original news on TUT website.
The application instructions can be found on www.fibrenet.eu/positions.

Centre of Excellence in Body-on-Chip Research and MEMO Consortium Project Invite Applications for Several Research Positions

The new Centre of Excellence in Body-on-Chip Research (CoEBoC) that is operated jointly by Tampere University of Technology (TUT) and the University of Tampere (UTA) started its operations in January, 2018. The Centre is led by Professor Minna Kellomäki from TUT, and it also involves Jari Hyttinen and Pasi Kallio from TUT as well as Katriina Aalto-Setälä, Susanna Miettinen, and Susanna Narkilahti from UTA.

Also the MEMO consortium project aiming at the development of in vitro epilepsy model for epilepsy and funded by the Academy of Finland, started its operations at the same time.

Both the new research openings are founded on the strong research cooperation done between the research groups at BioMediTech in the past ten years.

We are happy to announce several new job openings in the new Centre of Excellence in Body-on-Chip Research and in MEMO consortium project:

at the University of Tampere:

Two fixed-term Postdoctoral Researchers at the Centre of Excellence in Body-on-Chip Research (CoEBoC)
Fixed-term Doctoral Researcher at the Centre of Excellence in Body-on-Chip Research (CoEBoC)
Fixed-term Doctoral Researcher at the Faculty of Medicine and Life Sciences (MEMO)

at the Tampere University of Technology:

Doctoral Researcher at the Centre of Excellence in Body-on-Chip Research (CoEBoC)
Three (3) Postdoctoral Researchers at the Centre of Excellence in Body-on-Chip Research (CoEBoC)

More information from: Mari Pekkanen-Mattila mari.pekkanen-mattila@uta.fi

A new international M.Sc. degree programme at TUT – application open for 2018!

The Faculty of Biomedical Sciences and Engineering at Tampere University of Technology (TUT) has launched a new Master’s degree programme in Biomedical Sciences and Engineering that will begin in autumn 2018 – the application is now open!

The Master’s degree programme in Biomedical Sciences and Engineering offers an international and multidisciplinary environment to learn from esteemed scientists at the faculty. The degree programme will provide students with broad career possibilities, equip them with expertise in advanced technologies at the engineering and health sciences interface as well as professional know-how for working in the industry, hospitals or in the academic world.

Three majors are available in the programme:

  • Health Technology and Informatics
  • Biomaterials and Tissue Engineering
  • Biomedical Micro- and Nanodevices

For more information on the degree programme, please see the webpage of the degree programme in Biomedical Sciences and Engineering.

The application period for English-language Master’s degree programmes at TUT is 13.12.2017–17.1.2018. More information on the application period can be found on the TUT webpage. Applications to the programmes are submitted online at Studyinfo.fi. The application period ends on 17 January 2018 at 15.00 (GMT+2).

For more specific information on the degree programme in Biomedical Sciences and Engineering, please contact masters_bmse@tut.fi.

Enterovirus vaccine can protect against virus-induced diabetes

Scientists at the University of Tampere (Finland) and the Karolinska Institutet (Sweden) have demonstrated that an enterovirus vaccine can protect against virus-induced diabetes in a mouse model for Type 1 diabetes.

Type 1 diabetes is increasing worldwide and to date, the exact causes of the disease are not known. Enteroviruses (the most common virus affecting humans) are one of the environmental factors that have been touted as a potential cause of the disease. In this study, Stone et al. have taken an initial step to determine the involvement of these viruses through testing the efficacy of a novel prototype vaccine in preventing experimental Type 1 diabetes after enterovirus infection.

“These exciting results showing that the vaccine completely protects against virus-induced diabetes indicate the potential that such a vaccine has for elucidating the role of enteroviruses in human Type 1 diabetes” says Prof. Malin Flodström-Tullberg at the Karolinska Institutet whose group were responsible for the pre-clinical studies.

The researchers are keen to continue pursuing these studies as confirmed by Dr Vesa Hytönen, who produced the prototype vaccine: “The model described in this paper provides an excellent platform to test further enterovirus vaccines which contain a greater number of potential diabetogenic viruses. Through these proof-of-concept studies we hope to develop and experimentally validate an enterovirus vaccine similar to the commonly used poliovirus vaccine, which has the potential to establish whether enteroviruses play a role in Type 1 diabetes.”

Read the original news about this study from the UTA website.

COPLA – from Research to a Medical Device

Ilkka Kiviranta, professor of orthopaedics at the University of Helsinki, and Minna Kellomäki, professor of biomaterials and tissue engineering from BioMediTech and the Tampere University of Technology, established a research consortium in 2009 to find a solution for the treatment of cartilage damage in weight-bearing joints as well as the prevention of arthrosis. This research continued into a successful Tekes Project where COPLA Scaffold was developed.

COPLA team won the Science Pitching competition at the SLUSH event in 2015. Now COPLA team have established Askel Healthcare Ltd. The COPLA Scaffold™ will appear on the market in September. COPLA is a great example of turning science innovations into business.

Read COPLA’s full story on University of Helsinki website.

BioMediTech Annual Reports 2016 now available

BioMediTech Annual Reports 2016 are now available both in English and in Finnish.

Body-on-Chip Research chosen for Centre of Excellence

The Academy of Finland has chosen 12 new Centres of Excellence for the years 2018–2025. The Centre of Excellence in Body-on-Chip Research at BioMediTech was one of them.

The Centre of Excellence in Body-on-Chip Research is coordinated by Tampere University of Technology (TUT) and located at BioMediTech, which is a joint institute operated in collaboration by TUT and University of Tampere. Professor Minna Kellomäki, Dean of the Faculty of Biomedical Sciences and Engineering at TUT and head of the CoE, rejoices about the consortium’s new status as a Centre of Excellence.

“This is our first time as a Centre of Excellence, even though we have a conducted research together for over ten years. Our new funding and status allow us to continue the work we started in the Tekes-funded Human Spare Parts project and to open up new venues of research”, Kellomäki says.

The new Centre of Excellence brings together expertise from biology and technology. Its goal is to create a new type of body-on-chip concept where cell cultures, blood vessels, and nerves are utilised to create networks of several cell or tissue cultures based on stem cells. A computerised nervous system measures, analyses, and controls the network system.

Read more on TUT website.

Professor Hannu Uusitalo’s group joining BioMediTech

The BioMediTech Board has accepted the application of the Professor Hannu Uusitalo’s Ophthalmology research group to join BioMediTech institute. The board met on 9 June, 2017. The research of the Ophthalmology group concentrates on translational and clinical eye and vision research.

The research group has in vitro and in vivo disease models for research on age-related macular degeneration and glaucoma and for diseases due to deviant retinal angiogenesis (diabetic retinopathy, wet age-related macular degeneration, retinopathy of prematurity). Models are also utilized in ocular pharmacology. The research group also has ongoing several research and development projects based on ophthalmic imaging and numerous clinical studies.

Read more about the research of the group.